Company
renovorx.com
Delivering Therapy Where it Matters
Also known as RenovoRx, RenovoRx, Inc.
- Status
- Operatingas of 2026-09-18
- Business model
- B2B
- Headquarters
- Mountain View, CA, United States
- Customers
- medical institutions
- Legal name
- RenovoRx, Inc.
- renovorx.com (opens in a new tab)
- LinkedIn (opens in a new tab)
- X (opens in a new tab)
- Press page (opens in a new tab)
- Careers (opens in a new tab)
Claim, correct or request removal
Record updated 28 September 2026
About
RenovoRx is a life sciences company developing innovative targeted oncology therapies and commercializing RenovoCath®, a novel, U.S. Food and Drug Administration (FDA)-cleared local drug-delivery device, targeting high unmet medical needs.
Funding snapshot
- Total raised
- $39.5MSEC form D sum, as of 2026-09-28Source (opens in a new tab)
- Latest round
- Round, $10M2026-03-20
Funding rounds
- Round, 2026
- $10M2026-03-20, SEC form D sold, 16 investors
- Round, 2024
- $11.1M2024-04-11, SEC form D sold, 172 investors
- Round, 2024
- $6.1M2024-01-26, SEC form D sold, 92 investors
- Round, 2018
- $8.3M2018-04-18, SEC form D sold, 21 investors
- Round, 2015
- $2.1M2015-12-07, SEC form D sold, 18 investors
- Round, 2013
- $1.1M2013-12-20, SEC form D sold, 11 investors
- Round, 2013
- $660K2013-01-23, SEC form D sold, 8 investors
Products
- Hardware
- RenovoCath
Loading relationship preview